Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Samuelsson

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
European Journal of Immunology|July 1, 1994
Lipopolysaccharide-dependent transactivation of the temporally regulated immunoglobulin heavy chain 3' enhancerV Arulampalam, P A Grant, A Samuelsson, et al.
Clinical Physiology and Functional Imaging|October 13, 2009
Urea clearance: a new method to register local changes in blood flow in rat skeletal muscle based on microdialysisS Farnebo, A Samuelsson, J Henriksson, et al.
Physics in Medicine and Biology|July 3, 1998
Calculation of absorbed dose distributions from dynamic wedgesP Storchi, E Woudstra, P Verlinde, et al.
The Journal of Hospital Infection|July 12, 2003
Clustering of enterococcal infections in a general intensive care unitA Samuelsson, J Jonasson, H-J Monstein, et al.
Acta Anaesthesiologica Scandinavica|February 18, 2005
Computed tomography--a possible aid in the diagnosis of smoke inhalation injury?A Reske, Z Bak, A Samuelsson, et al.
Clinical Nephrology|September 1, 1973
Idiopathic nephrotic syndrome of childhood: cyclophosphamide induced conversion from steroid refractory to highly steroid sensitive diseaseA Bergstrand, I Bollgren, A Samuelsson, et al.
AIDS (London, England)|February 1, 1993
Identification of four antibody-binding sites in the envelope proteins of simian immunodeficiency virus, SIVsmA Samuelsson, E Björling, P Putkonen, et al.
European Journal of Immunology|December 1, 1996
Human antibodies from phage libraries: neutralizing activity against human immunodeficiency virus type 1 equally improved after expression as Fab and IgG in mammalian cellsA Samuelsson, F Yari, J Hinkula, et al.
Virology|March 10, 1995
Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virusA Samuelsson, F Chiodi, P Ohman, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|October 6, 1997
Practical implementation of enhanced dynamic wedge in the CadPlan treatment planning systemA Samuelsson, K A Johansson, O Mattsson, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Immunology|July 1, 1994
Lipopolysaccharide-dependent transactivation of the temporally regulated immunoglobulin heavy chain 3' enhancerV Arulampalam, P A Grant, A Samuelsson, et al.
Clinical Physiology and Functional Imaging|October 13, 2009
Urea clearance: a new method to register local changes in blood flow in rat skeletal muscle based on microdialysisS Farnebo, A Samuelsson, J Henriksson, et al.
Physics in Medicine and Biology|July 3, 1998
Calculation of absorbed dose distributions from dynamic wedgesP Storchi, E Woudstra, P Verlinde, et al.
The Journal of Hospital Infection|July 12, 2003
Clustering of enterococcal infections in a general intensive care unitA Samuelsson, J Jonasson, H-J Monstein, et al.
Acta Anaesthesiologica Scandinavica|February 18, 2005
Computed tomography--a possible aid in the diagnosis of smoke inhalation injury?A Reske, Z Bak, A Samuelsson, et al.
Clinical Nephrology|September 1, 1973
Idiopathic nephrotic syndrome of childhood: cyclophosphamide induced conversion from steroid refractory to highly steroid sensitive diseaseA Bergstrand, I Bollgren, A Samuelsson, et al.
AIDS (London, England)|February 1, 1993
Identification of four antibody-binding sites in the envelope proteins of simian immunodeficiency virus, SIVsmA Samuelsson, E Björling, P Putkonen, et al.
European Journal of Immunology|December 1, 1996
Human antibodies from phage libraries: neutralizing activity against human immunodeficiency virus type 1 equally improved after expression as Fab and IgG in mammalian cellsA Samuelsson, F Yari, J Hinkula, et al.
Virology|March 10, 1995
Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virusA Samuelsson, F Chiodi, P Ohman, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|October 6, 1997
Practical implementation of enhanced dynamic wedge in the CadPlan treatment planning systemA Samuelsson, K A Johansson, O Mattsson, et al.
Pageof 6